National Guideline Clearinghouse | Eltrombopag for treating chronic immune (idiopathic) thrombocytopenic purpura (review of technology appraisal 205).

full-text ►

National Guideline Clearinghouse | Eltrombopag for treating chronic immune (idiopathic) thrombocytopenic purpura (review of technology appraisal 205).





National Institute for Health and Care Excellence (NICE)

February 3, 2014

Guideline Title

Eltrombopag for treating chronic immune (idiopathic) thrombocytopenic purpura (review of technology appraisal 205).

Bibliographic Source(s)

National Institute for Health and Care Excellence (NICE). Eltrombopag for treating chronic immune (idiopathic) thrombocytopenic purpura (review of technology appraisal 205). London (UK): National Institute for Health and Care Excellence (NICE); 2013 Jul. 57 p. (Technology appraisal guidance; no. 293).

Guideline Status

This is the current release of the guideline.

This guideline updates a previous version: National Institute for Health and Clinical Excellence (NICE). Eltrombopag for the treatment of chronic immune (idiopathic) thrombocytopenic purpura. London (UK): National Institute for Health and Clinical Excellence (NICE); 2010 Oct. 47 p. (Technology appraisal guidance; no. 205).